Tata Group companies are buzzing on the bourses. At least 10 out of 17 companies of the Group have outperformed Sensex, taking into consideration the market movement since July 1, 2020.

On Thursday, with RBI's announcement of keeping the repo rate unchanged at four per cent, Sensex rose by 362.12 points or by 0.96 per cent to close at 38,025.45 while its NSE counterpart Nifty gained by 98.50 points or 0.89 per cent to end at 11,200.15.

Lupin Limited announced on Thursday that it has received approval from United States Food and Drug Administration (USFDA) for Mycophenolate Mofetil tablets USP, 500 mg, to market a generic version of CellCept® tablets of Roche Palo Alto LLC (Roche) in alliance with Concord Biotech Limited.

Meghmani Organics Limited’s subsidiary Meghmani Finechem Ltd (MFL) has started its commercial production of Hydrogen Peroxide (H2O2) from July 30, 2020, after the successful completion of the installation of integrated Hydrogen Peroxide plant in existing Chloralkali and Derivative complex at Dahej (Gujarat).

Gilt funds have generated returns in double-digit in the last one year. Should you invest in them now?

Alkem Laboratories launched Alfluenza in India for the management of mild to moderate cases of COVID-19.

The market opened in green on August 6, 2020. 

The market opened in green on August 6, 2020, overall volumes in futures & options currently stand at 3,18,68,879 crore contracts with a turnover of Rs. 21,74,184.82 crore.

The market opened in green on August 5, 2020, overall volumes in futures & options currently stand at 2,11,51,827 crore contracts with a turnover of Rs. 14,46,632.04 crore.

Indoco Remedies Limited announced on Thursday that it has received approval from United States Food and Drug Administration (USFDA) for its ANDA for Olanzapine tablets USP 2.5mg, 5mg, 7.5 mg, 10mg, 15mg, and 20 mg.